NCT03068442View on ClinicalTrials.gov

The Role of Large Artery Plaque Imaging Features in Predicting Inflammation and Cognition

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 17, 2017

Primary Completion Date

September 10, 2024

Study Completion Date

September 10, 2024

Conditions
Cognitive ImpairmentCarotid Artery PlaqueInflammation
Interventions
DRUG

Imaging with flutemetamol F 18 PET/CT

All subjects will undergo diagnostic imaging as the intervention. This imaging will be with flutemetamol F 18 PET/CT

Trial Locations (2)

84132

University of Utah, Salt Lake City

84148

George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

Scott Mcnally

OTHER